Literature DB >> 29596117

Multiple Solid Organ Transplantation in Telomeropathy: Case Series and Literature Review.

Marnix Lebeer1, Wim A Wuyts1, David Cassiman2, Wim Laleman2, Frederik Nevens2, Jacques Pirenne3, Diethard Monbaliu3, Tania Roskams4, Eric K Verbeken4, Arne P Neyrinck5, Dirk E Van Raemdonck6,7, Geert M Verleden1,7, Robin Vos1,7.   

Abstract

BACKGROUND: Solid organ transplantation is a valid treatment option for selected patients with organ failure due to an underlying telomeropathy; however, the feasibility of multiple-organ transplantation if several organs are compromised is unclear.
METHODS: We describe 2 patients with telomeropathy due to heterozygous telomerase RNA component or telomerase reverse transcriptase mutation, who successfully underwent serial or combined liver and lung transplantation for concurrent liver fibrosis/cirrhosis and pulmonary fibrosis.
RESULTS: Despite a challenging posttransplant course, long-term outcomes were favorable, with both patients doing fine now, respectively, 12/20 and 24 months after multiple-organ transplantation.
CONCLUSIONS: To our knowledge, this is the first report of multiple solid organ transplantation in documented telomeropathy. These cases highlight current difficulties of timely diagnosis, therapeutic approach, and postoperative complications in telomeropathy patients in whom several organs are affected.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29596117     DOI: 10.1097/TP.0000000000002198

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Disease progression and clinical outcomes in telomere biology disorders.

Authors:  Marena R Niewisch; Neelam Giri; Lisa J McReynolds; Rotana Alsaggaf; Sonia Bhala; Blanche P Alter; Sharon A Savage
Journal:  Blood       Date:  2022-03-24       Impact factor: 25.476

2.  Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase Mutation.

Authors:  Jennifer M Kolb; Kendra Conzen; Michael Wachs; Joseph Crossno; Brandon McMahon; Maheen Z Abidi; Elizabeth A Pomfret; Michael Kriss
Journal:  Hepatology       Date:  2020-07       Impact factor: 17.425

Review 3.  An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Authors:  Marena R Niewisch; Sharon A Savage
Journal:  Expert Rev Hematol       Date:  2019-09-10       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.